Epstein Secrets

rre Gentin Managing Director, Legal and Risk Credit Suisse USA William W. George Professor of Management Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Public Leadership Harvard Kennedy School USA V

ssion, Brussels Luke J. Daly Founder and Chief Executive Officer Ferrate Treatment USA Technologies Winston DamanIlo Chief Executive Officer Morphlabs Inc. USA Kommer Damen Chairman Damen Shipyards Group Netherlands Brian A. Dames Chief Executive Officer Eskom Holdings Limited South Africa Dang

rre Gentin Managing Director, Legal and Risk Credit Suisse USA William W. George Professor of Management Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Public Leadership Harvard Kennedy School USA V

ssion, Brussels Luke J. Daly Founder and Chief Executive Officer Ferrate Treatment USA Technologies Winston DamanIlo Chief Executive Officer Morphlabs Inc. USA Kommer Damen Chairman Damen Shipyards Group Netherlands Brian A. Dames Chief Executive Officer Eskom Holdings Limited South Africa Dang

USA USA Germany Switzerland USA USA World Economic Forum Annual Meeting EFTA_R1_02105175 EFTA02707407 President, Merck Vaccines MSD USA Julie Louise Gerberding Mikhail Gerchuk Mohammad Abdullah Al Gergawi David R. Gergen Valery Gergiev Natalia Germanova Olaf Gersemann Alan Gershenhorn Mi

Bloomberg News USA MasterCard International USA Incorporated Citadel Capital SAE Purpose Siemens AG Research in Motion Limited LANXESS AG Morphlabs Inc. Aftenposten Harvard Business Review Rensselaer Polytechnic Institute (RPI) Royal Philips Electronics Egypt USA Germany Canada Germany USA